ATE335729T1 - 3h-chinazoline -4-on derivaten - Google Patents
3h-chinazoline -4-on derivatenInfo
- Publication number
- ATE335729T1 ATE335729T1 AT03789170T AT03789170T ATE335729T1 AT E335729 T1 ATE335729 T1 AT E335729T1 AT 03789170 T AT03789170 T AT 03789170T AT 03789170 T AT03789170 T AT 03789170T AT E335729 T1 ATE335729 T1 AT E335729T1
- Authority
- AT
- Austria
- Prior art keywords
- chinazoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02027700 | 2002-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE335729T1 true ATE335729T1 (de) | 2006-09-15 |
Family
ID=32524001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03789170T ATE335729T1 (de) | 2002-12-13 | 2003-12-08 | 3h-chinazoline -4-on derivaten |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7087612B2 (de) |
| EP (1) | EP1572666B1 (de) |
| JP (1) | JP4384053B2 (de) |
| KR (1) | KR100707532B1 (de) |
| CN (1) | CN100418954C (de) |
| AR (1) | AR042362A1 (de) |
| AT (1) | ATE335729T1 (de) |
| AU (1) | AU2003293798B8 (de) |
| BR (1) | BR0317282A (de) |
| CA (1) | CA2509633A1 (de) |
| CL (1) | CL2003002565A1 (de) |
| DE (1) | DE60307512T2 (de) |
| ES (1) | ES2270154T3 (de) |
| GT (1) | GT200300284A (de) |
| MX (1) | MXPA05006124A (de) |
| MY (1) | MY141743A (de) |
| PA (1) | PA8591901A1 (de) |
| PE (1) | PE20040911A1 (de) |
| PL (1) | PL377474A1 (de) |
| RU (1) | RU2340604C2 (de) |
| TW (1) | TW200424180A (de) |
| UY (1) | UY28120A1 (de) |
| WO (1) | WO2004054985A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7846915B2 (en) | 2004-10-20 | 2010-12-07 | Resverlogix Corporation | Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases |
| CN101128189A (zh) | 2005-02-25 | 2008-02-20 | 弗·哈夫曼-拉罗切有限公司 | 药物物质分散性改善的片剂 |
| US8410109B2 (en) | 2005-07-29 | 2013-04-02 | Resverlogix Corp. | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| GB0525068D0 (en) * | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| JP4876690B2 (ja) * | 2006-04-21 | 2012-02-15 | 三菱瓦斯化学株式会社 | キナゾリン−４−オン誘導体の製造法 |
| JPWO2008087736A1 (ja) * | 2007-01-19 | 2010-05-06 | 宇部興産株式会社 | アラルキルオキシ又はヘテロアラルキルオキシ基を有する芳香族アミンの製法 |
| MX2009008099A (es) | 2007-02-01 | 2009-12-14 | Resverlogix Corp | Compuestos para la prevencion y tratamiento de enfermedades cardiovasculares. |
| KR101629356B1 (ko) | 2008-06-26 | 2016-06-13 | 리스버로직스 코퍼레이션 | 퀴나졸리논 유도체의 제조방법 |
| CA2747417C (en) | 2009-01-08 | 2017-01-03 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
| KR101913109B1 (ko) | 2009-03-18 | 2018-10-31 | 리스버로직스 코퍼레이션 | 신규한 소염제 |
| DK2421533T3 (en) | 2009-04-22 | 2019-01-07 | Resverlogix Corp | Hitherto unknown anti-inflammatory agents |
| LT2773354T (lt) | 2011-11-01 | 2019-08-12 | Resverlogix Corp. | Geriamosios greitai atsipalaiduojančios pakeistų chinozolinų vaisto formos |
| US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
| WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
| WO2014096965A2 (en) | 2012-12-21 | 2014-06-26 | Rvx Therapeutics Inc. | Novel heterocyclic compounds as bromodomain inhibitors |
| JP6903585B2 (ja) | 2015-03-13 | 2021-07-14 | レスバーロジックス コーポレイション | 補体関連疾患の治療のための組成物および治療方法 |
| CN106146410B (zh) * | 2015-04-03 | 2018-10-12 | 中南大学 | 6-氨基-4(3h)-喹唑啉酮衍生物及其合成方法和用途 |
| CN108191667B (zh) * | 2018-01-04 | 2021-03-26 | 利尔化学股份有限公司 | 2-硝基-4-三氟甲基苯甲酸甲酯的制备方法 |
| CN109553534A (zh) * | 2018-11-27 | 2019-04-02 | 常州大学 | 一种2-硝基-4-甲氧基苯甲酸的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6136273A (ja) * | 1984-07-26 | 1986-02-20 | Mitsubishi Yuka Yakuhin Kk | ２−フエニルアルキル−４（３ｈ）−キナゾリノン誘導体 |
| JP3194963B2 (ja) * | 1995-03-14 | 2001-08-06 | ノバルティス・アクチエンゲゼルシャフト | 三置換フェニル誘導体 |
| IL117659A (en) * | 1995-04-13 | 2000-12-06 | Dainippon Pharmaceutical Co | Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same |
| US5679715A (en) | 1995-06-07 | 1997-10-21 | Harris; Richard Y. | Method for treating multiple sclerosis |
| US5783577A (en) * | 1995-09-15 | 1998-07-21 | Trega Biosciences, Inc. | Synthesis of quinazolinone libraries and derivatives thereof |
| WO1997033572A1 (en) | 1996-03-15 | 1997-09-18 | Somerset Pharmaceuticals, Inc. | Method for preventing and treating peripheral neurophathy by administering selegiline |
| ATE368665T1 (de) * | 1997-08-22 | 2007-08-15 | Astrazeneca Ab | Oxindolylchinazolinderivate als angiogenesehemmer |
| US6890930B1 (en) * | 1999-09-28 | 2005-05-10 | 3-Dimensional Pharmaceuticals, Inc. | Quinazolinones |
| WO2001034172A2 (en) | 1999-11-05 | 2001-05-17 | Vela Pharmaceuticals Inc. | Methods and compositions for treating reward deficiency syndrome |
-
2003
- 2003-12-08 MX MXPA05006124A patent/MXPA05006124A/es active IP Right Grant
- 2003-12-08 EP EP03789170A patent/EP1572666B1/de not_active Expired - Lifetime
- 2003-12-08 RU RU2005121908/04A patent/RU2340604C2/ru not_active IP Right Cessation
- 2003-12-08 AU AU2003293798A patent/AU2003293798B8/en not_active Ceased
- 2003-12-08 WO PCT/EP2003/013888 patent/WO2004054985A1/en not_active Ceased
- 2003-12-08 AT AT03789170T patent/ATE335729T1/de not_active IP Right Cessation
- 2003-12-08 BR BR0317282-1A patent/BR0317282A/pt not_active IP Right Cessation
- 2003-12-08 PL PL377474A patent/PL377474A1/pl not_active Application Discontinuation
- 2003-12-08 JP JP2004559781A patent/JP4384053B2/ja not_active Expired - Lifetime
- 2003-12-08 CA CA002509633A patent/CA2509633A1/en not_active Abandoned
- 2003-12-08 KR KR1020057010696A patent/KR100707532B1/ko not_active Expired - Fee Related
- 2003-12-08 DE DE60307512T patent/DE60307512T2/de not_active Expired - Lifetime
- 2003-12-08 ES ES03789170T patent/ES2270154T3/es not_active Expired - Lifetime
- 2003-12-08 CN CNB2003801052982A patent/CN100418954C/zh not_active Expired - Fee Related
- 2003-12-09 TW TW092134699A patent/TW200424180A/zh unknown
- 2003-12-10 PE PE2003001256A patent/PE20040911A1/es not_active Application Discontinuation
- 2003-12-10 CL CL200302565A patent/CL2003002565A1/es unknown
- 2003-12-10 PA PA20038591901A patent/PA8591901A1/es unknown
- 2003-12-11 UY UY28120A patent/UY28120A1/es not_active Application Discontinuation
- 2003-12-11 GT GT200300284A patent/GT200300284A/es unknown
- 2003-12-11 AR ARP030104562A patent/AR042362A1/es unknown
- 2003-12-12 MY MYPI20034764A patent/MY141743A/en unknown
- 2003-12-13 US US10/734,949 patent/US7087612B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1572666A1 (de) | 2005-09-14 |
| BR0317282A (pt) | 2005-11-08 |
| TW200424180A (en) | 2004-11-16 |
| US7087612B2 (en) | 2006-08-08 |
| EP1572666B1 (de) | 2006-08-09 |
| RU2005121908A (ru) | 2006-01-27 |
| WO2004054985A1 (en) | 2004-07-01 |
| UY28120A1 (es) | 2004-06-30 |
| US20040142951A1 (en) | 2004-07-22 |
| DE60307512T2 (de) | 2007-02-08 |
| CA2509633A1 (en) | 2004-07-01 |
| CL2003002565A1 (es) | 2005-01-07 |
| PA8591901A1 (es) | 2004-11-26 |
| MY141743A (en) | 2010-06-30 |
| AU2003293798B8 (en) | 2009-02-12 |
| RU2340604C2 (ru) | 2008-12-10 |
| JP2006513177A (ja) | 2006-04-20 |
| CN100418954C (zh) | 2008-09-17 |
| KR100707532B1 (ko) | 2007-04-12 |
| PE20040911A1 (es) | 2004-12-11 |
| MXPA05006124A (es) | 2005-08-16 |
| JP4384053B2 (ja) | 2009-12-16 |
| ES2270154T3 (es) | 2007-04-01 |
| PL377474A1 (pl) | 2006-02-06 |
| KR20050085587A (ko) | 2005-08-29 |
| AU2003293798B2 (en) | 2009-01-15 |
| AR042362A1 (es) | 2005-06-15 |
| DE60307512D1 (de) | 2006-09-21 |
| AU2003293798A1 (en) | 2004-07-09 |
| CN1720237A (zh) | 2006-01-11 |
| GT200300284A (es) | 2004-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE478870T1 (de) | Spiroindolinpiperidinderivate | |
| DK1556385T3 (da) | Heterocyclocarboxamid-derivater | |
| DE60330372D1 (de) | Indol-3-schwefelderivate | |
| ATE467631T1 (de) | Chinuclidinamidderivate | |
| ATE438644T1 (de) | Chinazolinderivate | |
| IS7720A (is) | Píperidín-N-oxíð-afleiður | |
| DK1474408T3 (da) | N-Phenyl-2-pyrimidinaminderivater | |
| DK1594840T3 (da) | Piperidin-benzensulfonamid-derivater | |
| ATE352550T1 (de) | Chinazolinderivate | |
| ATE420066T1 (de) | Amidoacetonitrilderivate | |
| ATE395345T1 (de) | Imidazol-4-yl-ethynyl-pyridin-derivate | |
| DE60307512D1 (de) | 3h-chinazoline -4-on derivaten | |
| ATE354365T1 (de) | N-thiazol-2-yl-benzamid-derivate | |
| ATE423771T1 (de) | Tetrahydrochinolinderivate | |
| ATE457299T1 (de) | 4-hydroxymethyl-1-aryl-cyclohexylamin-derivativ | |
| DK1706373T3 (da) | Amidoacetonitrilderivater | |
| IS8045A (is) | Púrín-6-ón-afleiður | |
| ATA4142004A (de) | Trägerverbau | |
| DE50306277D1 (de) | 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate | |
| DE50305973D1 (de) | Auffangwanne | |
| IS7906A (is) | Afleiður própargýl-tríflúorómetoxý-amínó-benzóþíazóls | |
| AT5889U3 (de) | Brennholzspleisser | |
| ATA16872002A (de) | Zwischenstück | |
| ATE395327T1 (de) | Amidoacetonitrilderivate | |
| DK1503988T3 (da) | Fredericamycin-derivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1572666 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |